July/August 2014 Issue
Ten steps need to be taken to help payers more adequately address the problem of inappropriate prescribing of pain medications.
Our analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.
Adherence among seniors to 3 widely used chronic medication classes differed by medication burden, patient characteristics, and specific comorbid conditions.
Recent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.